Pamela Crilley, DO | Authors


The Impact of CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma

March 30, 2021

The paradigm for management of relapsed myeloma is evolving rapidly with a plethora of treatment options based on results of clinical trials. One explosive area of scientific and clinical research is the investigation of chimeric antigen receptor T-cell therapy.